Platelet activation in experimental murine neonatal pulmonary hypertension

Abstract Serotonin (5‐HT) contributes to the pathogenesis of experimental neonatal pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD). Platelets are the primary source of circulating 5‐HT and is released upon platelet activation. Platelet transfusions are associated with ne...

Full description

Bibliographic Details
Main Authors: Pavel Davizon‐Castillo, Ayed Allawzi, Matthew Sorrells, Susan Fisher, Kristina Baltrunaite, Keith Neeves, Eva Nozik‐Grayck, Jorge DiPaola, Cassidy Delaney
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.14386
id doaj-2db647b80d8e498eb505a0937c5d1f65
record_format Article
spelling doaj-2db647b80d8e498eb505a0937c5d1f652020-11-25T03:10:59ZengWileyPhysiological Reports2051-817X2020-03-0185n/an/a10.14814/phy2.14386Platelet activation in experimental murine neonatal pulmonary hypertensionPavel Davizon‐Castillo0Ayed Allawzi1Matthew Sorrells2Susan Fisher3Kristina Baltrunaite4Keith Neeves5Eva Nozik‐Grayck6Jorge DiPaola7Cassidy Delaney8Section of Pediatric Hematology, Oncology, and Bone Marrow Transplant University of Colorado Anschutz Medical Campus Aurora CO USASection of Pediatric Critical Care and Cardiovascular Pulmonary Research Laboratory University of Colorado Anschutz Medical Campus Aurora CO USADepartment of Chemical and Biological Engineering Colorado School of Mines Golden CO USASection of Neonatology Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora CO USASection of Neonatology Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora CO USASection of Pediatric Hematology, Oncology, and Bone Marrow Transplant University of Colorado Anschutz Medical Campus Aurora CO USASection of Pediatric Critical Care and Cardiovascular Pulmonary Research Laboratory University of Colorado Anschutz Medical Campus Aurora CO USADivision of Pediatric Hematology Oncology Washington University in St. Louis St. Louis MO USASection of Neonatology Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora CO USAAbstract Serotonin (5‐HT) contributes to the pathogenesis of experimental neonatal pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD). Platelets are the primary source of circulating 5‐HT and is released upon platelet activation. Platelet transfusions are associated with neonatal mortality and increased rates of BPD. As BPD is often complicated by PH, we tested the hypothesis that circulating platelets are activated and also increased in the lungs of neonatal mice with bleomycin‐induced PH associated with BPD. Newborn wild‐type mice received intraperitoneal bleomycin (3 units/kg) three times weekly for 3 weeks. Platelets from mice with experimental PH exhibited increased adhesion to collagen under flow (at 300 s−1 and 1,500 s−1) and increased expression of the αIIbβ3 integrin and phosphatidylserine, markers of platelet activation. Platelet‐derived factors 5‐HT and platelet factor 4 were increased in plasma from mice with experimental PH. Pharmacologic blockade of the 5‐HT 2A receptor (5‐HT 2A R) prevents bleomycin‐induced PH and pulmonary vascular remodeling. Here, platelets from mice with bleomycin‐induced PH demonstrate increased 5‐HT 2A R expression providing further evidence of both platelet activation and increased 5‐HT signaling in this model. In addition, bleomycin treatment increased lung platelet accumulation. In summary, platelets are activated, granule factors are released, and are increased in numbers in the lungs of mice with experimental neonatal PH. These results suggest platelet activation and release of platelet‐derived factors may increase vascular tone, promote aberrant angiogenesis, and contribute to the development of neonatal PH.https://doi.org/10.14814/phy2.14386neonateplateletspulmonary hypertensionserotonin
collection DOAJ
language English
format Article
sources DOAJ
author Pavel Davizon‐Castillo
Ayed Allawzi
Matthew Sorrells
Susan Fisher
Kristina Baltrunaite
Keith Neeves
Eva Nozik‐Grayck
Jorge DiPaola
Cassidy Delaney
spellingShingle Pavel Davizon‐Castillo
Ayed Allawzi
Matthew Sorrells
Susan Fisher
Kristina Baltrunaite
Keith Neeves
Eva Nozik‐Grayck
Jorge DiPaola
Cassidy Delaney
Platelet activation in experimental murine neonatal pulmonary hypertension
Physiological Reports
neonate
platelets
pulmonary hypertension
serotonin
author_facet Pavel Davizon‐Castillo
Ayed Allawzi
Matthew Sorrells
Susan Fisher
Kristina Baltrunaite
Keith Neeves
Eva Nozik‐Grayck
Jorge DiPaola
Cassidy Delaney
author_sort Pavel Davizon‐Castillo
title Platelet activation in experimental murine neonatal pulmonary hypertension
title_short Platelet activation in experimental murine neonatal pulmonary hypertension
title_full Platelet activation in experimental murine neonatal pulmonary hypertension
title_fullStr Platelet activation in experimental murine neonatal pulmonary hypertension
title_full_unstemmed Platelet activation in experimental murine neonatal pulmonary hypertension
title_sort platelet activation in experimental murine neonatal pulmonary hypertension
publisher Wiley
series Physiological Reports
issn 2051-817X
publishDate 2020-03-01
description Abstract Serotonin (5‐HT) contributes to the pathogenesis of experimental neonatal pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD). Platelets are the primary source of circulating 5‐HT and is released upon platelet activation. Platelet transfusions are associated with neonatal mortality and increased rates of BPD. As BPD is often complicated by PH, we tested the hypothesis that circulating platelets are activated and also increased in the lungs of neonatal mice with bleomycin‐induced PH associated with BPD. Newborn wild‐type mice received intraperitoneal bleomycin (3 units/kg) three times weekly for 3 weeks. Platelets from mice with experimental PH exhibited increased adhesion to collagen under flow (at 300 s−1 and 1,500 s−1) and increased expression of the αIIbβ3 integrin and phosphatidylserine, markers of platelet activation. Platelet‐derived factors 5‐HT and platelet factor 4 were increased in plasma from mice with experimental PH. Pharmacologic blockade of the 5‐HT 2A receptor (5‐HT 2A R) prevents bleomycin‐induced PH and pulmonary vascular remodeling. Here, platelets from mice with bleomycin‐induced PH demonstrate increased 5‐HT 2A R expression providing further evidence of both platelet activation and increased 5‐HT signaling in this model. In addition, bleomycin treatment increased lung platelet accumulation. In summary, platelets are activated, granule factors are released, and are increased in numbers in the lungs of mice with experimental neonatal PH. These results suggest platelet activation and release of platelet‐derived factors may increase vascular tone, promote aberrant angiogenesis, and contribute to the development of neonatal PH.
topic neonate
platelets
pulmonary hypertension
serotonin
url https://doi.org/10.14814/phy2.14386
work_keys_str_mv AT paveldavizoncastillo plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT ayedallawzi plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT matthewsorrells plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT susanfisher plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT kristinabaltrunaite plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT keithneeves plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT evanozikgrayck plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT jorgedipaola plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
AT cassidydelaney plateletactivationinexperimentalmurineneonatalpulmonaryhypertension
_version_ 1724655902054678528